# ClinicalTrials.gov record NCT06994338

> PeptideScanner retained ClinicalTrials.gov record NCT06994338 at 2026-07-30T18:20:54.428Z. Its registry update date was 2025-10-14, and PeptideScanner's reviewed identity mapping was tirzepatide.

- Evidence object: `story:clinicaltrials-gov-nct06994338-tirzepatide:v1`
- Evidence domain: Clinical trials
- Date in source: 2025-10-14
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct06994338-tirzepatide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct06994338-tirzepatide-v1.json
- Content SHA-256: `cffd09aa820d68c0768741d2307058214da2e6d8cff041fa5ee4c197f8bb8772`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT06994338 ([`ctg-observation-nct06994338-2025-10-14-a5ec3b86cdb7`](#source-ctg-observation-nct06994338-2025-10-14-a5ec3b86cdb7))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT06994338 at 2026-07-30T18:20:54.428Z. Its registry update date was 2025-10-14, and PeptideScanner's reviewed identity mapping was tirzepatide. ([`ctg-observation-nct06994338-2025-10-14-a5ec3b86cdb7`](#source-ctg-observation-nct06994338-2025-10-14-a5ec3b86cdb7))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT06994338 at 2026-07-30T18:20:54.428Z. Its registry update date was 2025-10-14, and PeptideScanner's reviewed identity mapping was tirzepatide. ([`ctg-observation-nct06994338-2025-10-14-a5ec3b86cdb7`](#source-ctg-observation-nct06994338-2025-10-14-a5ec3b86cdb7))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct06994338-2025-10-14-a5ec3b86cdb7`](#source-ctg-observation-nct06994338-2025-10-14-a5ec3b86cdb7))

## Sources

<a id="source-ctg-observation-nct06994338-2025-10-14-a5ec3b86cdb7"></a>
- **ClinicalTrials.gov record NCT06994338 · retained source version 2025-10-14:a5ec3b86cdb716f6517c38c4556eafca2a98da760b72dd47a73a4ab2fd4338eb** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT06994338) (`ctg-observation-nct06994338-2025-10-14-a5ec3b86cdb7`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT06994338." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct06994338-tirzepatide-v1.json SHA-256: cffd09aa820d68c0768741d2307058214da2e6d8cff041fa5ee4c197f8bb8772.